Central South University

This study looks at whether the diabetes drug metformin can help prevent blood sugar problems caused by statins (cholesterol-lowering drugs) in people with schizophrenia. About 400 adults with stable schizophrenia will take either metformin or a placebo alongside their statin for…

This study tests whether metformin, a common diabetes medication, can improve memory and thinking in people with schizophrenia. Researchers will give 120 participants either metformin or a placebo for 24 weeks and measure changes in cognitive tests and brain scans. The goal is to…

This study tests whether a non-invasive brain stimulation technique called navigated transcranial magnetic stimulation (nTMS) can reduce negative symptoms of schizophrenia, such as lack of motivation, social withdrawal, and reduced speech. Forty adults with schizophrenia will rec…

This study looks at 300 people with early-stage lung cancer to understand why some tumors grow differently. Researchers will analyze genes, immune cells, and other markers from tumor samples. The goal is to find better ways to predict cancer return and identify new treatment targ…

This study looks at 500 people with a rare type of lung cancer that has air-filled cysts. Researchers want to find the best way to measure the tumor size to improve staging and predict outcomes. The goal is to help doctors make better treatment decisions for this specific cancer.

This study uses artificial intelligence to analyze patient data—like medical history, scans, and lab results—to predict how well esophageal cancer responds to chemotherapy and immunotherapy before surgery. Researchers aim to identify which patients achieve a complete response and…